Share on StockTwits

CryoLife (NYSE:CRY) VP Jeffrey W. Burris sold 11,000 shares of the stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $10.50, for a total transaction of $115,500.00. Following the sale, the vice president now directly owns 93,576 shares in the company, valued at approximately $982,548. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

CryoLife (NYSE:CRY) opened at 10.43 on Monday. CryoLife has a one year low of $6.01 and a one year high of $12.14. The stock’s 50-day moving average is $9.52 and its 200-day moving average is $9.50. The company has a market cap of $291.3 million and a price-to-earnings ratio of 19.46.

CryoLife (NYSE:CRY) last released its earnings data on Thursday, July 24th. The company reported $0.08 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.05 by $0.03. The company had revenue of $34.69 million for the quarter, compared to the consensus estimate of $35.72 million. During the same quarter in the previous year, the company posted $0.08 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts expect that CryoLife will post $0.20 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, September 19th. Investors of record on Friday, September 12th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Wednesday, September 10th.

CryoLife, Inc (NYSE:CRY) is a biological medical device company.

Receive News & Ratings for CryoLife Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoLife Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.